A modular cell-culture platform demonstrates accelerated process development.
Markus Michael Mueller
Advertisement
Markus Michael Mueller is associate director, cell culture development at Boehringer Ingelheim Pharma GmbH & Co. KG.
Articles by Markus Michael Mueller
Advertisement
Latest Updated Articles
Platform Approach Speeds Process DevelopmentPublished: April 1st 2016 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
